FDA delays decision on first drug to prevent HIV infection

   Jun 9, 4:37 pm

London, June 9 (ANI): US health regulators have delayed until mid-September a decision on whether to approve Truvada as the first pill that prevents HIV infection.

Drug maker Gilead Sciences said on Friday that the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California Company submitted additional materials to the agency earlier this month.

In May, a panel of experts recommended approval of the daily pill for healthy people at high risk of contracting HIV, the Daily Express reported.

The group's vote is non-binding, but the FDA often follows its advice.

Gilead said that it had submitted updated details on its safety materials for patients and doctors using Truvada.

The FDA typically extends its reviews after receiving such information. (ANI)

India's top neuro-oncologists to meet in Kochi to deliberate on tumour treatment advances Mar 26, 11:12 am
Kochi (Kerala), Mar.26 (ANI): India's top neuro-oncologists will deliberate for three days, advancements in treatment and understanding of brain tumours.
Full Story
This new tool helps chart risks of heart attack, stroke for anyone in world aged over 40 Mar 26, 10:48 am
London, Mar.26 (ANI): A new tool, dubbed as Globorisk, can help chart risks of heart attack, stroke for anyone in world aged over 40.
Full Story
3 glasses of booze per day may cause liver cancer Mar 25, 4:42 pm
London, March 25 (ANI): If you are a regular drinker, you might want to put that gas down, as new study has revealed that consuming 3 glasses of alcohol per day can cause liver cancer.
Full Story
'Fats' may help treat type 2 diabetes Mar 25, 3:20 pm
Washington, Mar 25 (ANI): A new research has discovered that fats were a 'new weapon' in the war against type 2 diabetes and play an important role to treat it.
Full Story
Comments

LATEST STORIES
TOP VIDEO STORIES
PHOTO GALLERY